ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
40.63
0.12%
US Tech 100
21,156.80
-0.70%
S&P 500
6,101.24
-0.29%
US Dollar vs CAD
1.44878
0.00%
Bitcoin
104,469.12
-0.25%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Germany
  5. TG

  6. Essilorluxottica (ESL) Share Price

Essilorluxottica

Essilorluxottica (ESL)

Eco Systems Ltd
255.30
-1.00
(-0.39%)
Closed January 26 3:00PM
Realtime Data

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
255.30
Bid
254.90
Ask
255.60
Volume
1,541
252.80 Day's Range 257.10
176.84 52 Week Range 257.10
Market Cap
113.668B
Previous Close
256.30
Open
256.00
Last Trade
10
@
255.7
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
1,913
Shares Outstanding
445,231,933
Dividend Yield
1.55%
PE Ratio
51.74
Earnings Per Share (EPS)
5.14
Revenue
25.4B
Net Profit
2.29B

About Essilorluxottica

Sector
Ophthalmic Goods
Industry
Ophthalmic Goods
Website
www.essilorluxottica.com
Headquarters
Charenton-le-pont, Val-de-marne, Fra
Founded
1971
Essilorluxottica is listed in the Ophthalmic Goods sector of the Tradegate (DE) with ticker ESL. The last closing price for Essilorluxottica was 256.30 €. Over the last year, Essilorluxottica shares have traded in a share price range of 176.84 € to 257.10 €.

Essilorluxottica currently has 445,231,933 shares outstanding. The market capitalization of Essilorluxottica is 114.11 € billion. Essilorluxottica has a price to earnings ratio (PE ratio) of 51.74.

Ask ADVFN Intelligence (AI)

ESL Latest News

More News

EssilorLuxottica: Déclaration de transactions sur actions propres

EssilorLuxottica: Déclaration de transactions sur actions propres Déclaration de transactions sur actions propres Paris, France (21 janvier 2025, 18h00) – Conformément à l’autorisation octroyée...

January 21 2025
UK Regulatory

EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of December 31, 2024

EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of December 31, 2024 Disclosure of Share Capital and Voting Rights Outstanding as of December 31, 2024 (Pursuant to...

January 15 2025
UK Regulatory

EssilorLuxottica: Nombre total de droits de vote et d’actions composant le capital social au 31 décembre 2024

EssilorLuxottica: Nombre total de droits de vote et d’actions composant le capital social au 31 décembre 2024 Nombre total de droits de vote et d’actions composant le capital social au 31 décembre...

January 15 2025
UK Regulatory

EssilorLuxottica: Déclaration de transactions sur actions propres

EssilorLuxottica: Déclaration de transactions sur actions propres Déclaration de transactions sur actions propres Paris, France (14 janvier 2025, 18h00) – Conformément à l’autorisation octroyée...

January 14 2025
UK Regulatory

EssilorLuxottica: Déclaration de transactions sur actions propres

EssilorLuxottica: Déclaration de transactions sur actions propres Déclaration de transactions sur actions propres Paris, France (7 janvier 2025, 18h00) – Conformément à l’autorisation octroyée par...

January 07 2025
UK Regulatory

EssilorLuxottica si rafforza nelle soluzioni acustiche con l’acquisizione di una startup francese specializzata nell’IA

EssilorLuxottica si rafforza nelle soluzioni acustiche con l’acquisizione di una startup francese specializzata nell’IA EssilorLuxottica si rafforza nelle soluzioni acustiche con l’acquisizione di...

January 02 2025
UK Regulatory

EssilorLuxottica strengthens its presence in the hearing space with the acquisition of an AI-driven tech startup in France

EssilorLuxottica strengthens its presence in the hearing space with the acquisition of an AI-driven tech startup in France EssilorLuxottica strengthens its presence in the hearing space with the...

January 02 2025
UK Regulatory

EssilorLuxottica se renforce dans le domaine de l'audition avec l'acquisition d'une startup technologique française centrée sur l'IA

EssilorLuxottica se renforce dans le domaine de l'audition avec l'acquisition d'une startup technologique française centrée sur l'IA EssilorLuxottica se renforce dans le...

January 02 2025
UK Regulatory

EssilorLuxottica: Déclaration de transactions sur actions propres

EssilorLuxottica: Déclaration de transactions sur actions propres Déclaration de transactions sur actions propres Paris, France (31 décembre 2024, 8h00) – Conformément à l’autorisation octroyée...

December 31 2024
UK Regulatory

EssilorLuxottica: Déclaration de transactions sur actions propres

EssilorLuxottica: Déclaration de transactions sur actions propres Déclaration de transactions sur actions propres Paris, France (24 décembre 2024, 8h00) – Conformément à l’autorisation octroyée...

December 24 2024
UK Regulatory
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1145.80190634065241.3257.1240.61483250.84567651DE
423.19.94832041344232.2257.1229.51739237.67098598DE
1239.818.4686774942215.5257.12151913232.41581234DE
2658.3529.6268088347196.95257.1190.951683221.4539707DE
5276.1242.4824199129179.18257.1176.841560211.60509685DE
15683.148.2578397213172.2257.1132.8795198.02175515DE
26069.2437.2138019994186.06257.1132.8764197.73331975DE

ESL - Frequently Asked Questions (FAQ)

What is the current Essilorluxottica share price?
The current share price of Essilorluxottica is 255.30 €
How many Essilorluxottica shares are in issue?
Essilorluxottica has 445,231,933 shares in issue
What is the market cap of Essilorluxottica?
The market capitalisation of Essilorluxottica is EUR 114.11B
What is the 1 year trading range for Essilorluxottica share price?
Essilorluxottica has traded in the range of 176.84 € to 257.10 € during the past year
What is the PE ratio of Essilorluxottica?
The price to earnings ratio of Essilorluxottica is 51.74
What is the cash to sales ratio of Essilorluxottica?
The cash to sales ratio of Essilorluxottica is 4.66
What is the reporting currency for Essilorluxottica?
Essilorluxottica reports financial results in EUR
What is the latest annual turnover for Essilorluxottica?
The latest annual turnover of Essilorluxottica is EUR 25.4B
What is the latest annual profit for Essilorluxottica?
The latest annual profit of Essilorluxottica is EUR 2.29B
What is the registered address of Essilorluxottica?
The registered address for Essilorluxottica is 147 RUE DE PARIS, CHARENTON-LE-PONT, VAL-DE-MARNE, 94220
What is the Essilorluxottica website address?
The website address for Essilorluxottica is www.essilorluxottica.com
Which industry sector does Essilorluxottica operate in?
Essilorluxottica operates in the OPHTHALMIC GOODS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
LL3PanGenomic Health Inc
0.2999 €
(67.26%)
2.89k
VAR1Varta AG
1.00 €
(37.93%)
3.62M
FP9Five Point Holdings LLC
5.35 €
(36.48%)
20
UD9Mason Resources Inc
0.0616 €
(36.28%)
28k
8CTCannabix Technologies Inc
0.32 €
(33.33%)
250
E3TMetavista 3D Inc
1.49 €
(-50.99%)
5.26M
E3O1Nexoptic Technology Corp
0.008 €
(-48.39%)
34.02k
POTAPortofino Resources Inc
0.0032 €
(-38.46%)
150k
G12Global Atomic Corp
0.425 €
(-31.95%)
729.18k
1UR1Bee Vectoring Technologies International Inc
0.0035 €
(-30.00%)
139.6k
PF8European Lithium Limited
0.0348 €
(-3.33%)
9.79M
E3TMetavista 3D Inc
1.49 €
(-50.99%)
5.26M
D7GNel ASA
0.1932 €
(0.99%)
4.13M
0QJHexagon Purus ASA
0.2725 €
(-22.59%)
3.99M
VAR1Varta AG
1.00 €
(37.93%)
3.62M

Discussion

View Full Feed
EZmoney- EZmoney- 5 minutes ago
T53 guess who's back !!!
Truthsocial Truthsocial 5 minutes ago
FO DF
RDGL
ChannelTrader ChannelTrader 5 minutes ago
That would solve the problem.
Golden Cross Golden Cross 6 minutes ago
💲 000 Stocks Can make You Rich!
Golden Cross Golden Cross 7 minutes ago
💲 000 Stocks Can make You Rich!
arizona1 arizona1 8 minutes ago
Trump Supporters Are Begging Him For Their Jobs Back

https://substackcdn.com/image/fetch/w_2250,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fe1724342-3fad-42ff-b838-435b57d6caad_1125x720.jpeg

http
janice shell janice shell 9 minutes ago
Yes, of course. Uqora. The story of the founder, Jenna Ryan, is probably familiar to a very large number of women. Symptoms can be sort of vague, and they can change, and they can be hard to describe to a doctor. I think some kind of regime like the one they suggest makes sense. They evidently have
StayHumble StayHumble 10 minutes ago
perForbes Insiders CE0💹KevinLamb💹+💹Bryan Cranston wow $UBQU

https://x.com/CorporateUbqu/status/1802724359762506049
https://x.com/I_Outcomes/status/1812870363094626701

".......believe it... i'm insider too ......"
https://cdn.vo
UBQU
igotthemojo igotthemojo 10 minutes ago
about what i expected...i think its time for your nap little boy...
PLUG
Gmenfan Gmenfan 11 minutes ago
How much are second hand parachutes? And I'm being kind here.....
igotthemojo igotthemojo 11 minutes ago
i told you the last time you made that comment about yarn that it was stupid...and then you repeated the same nonsense...

you were DEAD WRONG then and you are DEAD WRONG now...

"And yes, we know, "this time is different"."

FINALLY you have stated somethin
KBLB
ilovetech ilovetech 12 minutes ago
If I were the CEO of NWBO, I would SERIOUSLY consider the block chain dividend strategy, which Danish posted about on X. That is unless LP has decided to go with a merger, for example, with a company like Revimmune to register under a new CUSP number, where both strategies have successfully squeeze
NWBO
Airfred Airfred 12 minutes ago
Love the idea I’ll sign

Long time reader first time writing
FNMA
Pnypnchr Pnypnchr 14 minutes ago
This is ihub, that will never change me.
BLTHD
Investor2014 Investor2014 14 minutes ago
Exactly, a correlation to actual endpoints of the trial must be established.
It also has yet to be shown to be correlated with or causative of clinical outcomes.

From there further trials would be needed, where brain atrophy reduction is confirmed correlated to cognitive and/or
AVXL
MightyX MightyX 15 minutes ago
Your homies allow-you to f-bomb..good show for-the public
TPTW
georgejjl georgejjl 15 minutes ago
Pantheon and Syntagon combined give Anavex the production process control and capacity to produce Blarcamesine for commercialization and worldwide distribution and sales.

https://patheon.com/

https://www.syntegon.com/company

Good luck and GOD bless,
AVXL
PEACHMAN PEACHMAN 15 minutes ago
Plenty of accurate due diligence and news available at IFUS website

https://impactfusionbrands.com/news/

IFUS STRONG
IFUS
StayHumble StayHumble 15 minutes ago
Update!💹FundersWait✅2Ensure $DBMM Still Trades✅idiot💹

$DBMM has the Ability to move forward, to continue to grow its business, benefits its shareholders and asks that the Commission affirm the decision of the Law Judge denying revocation of its regis
DBMM GTII HPIL
SHEEPWOLF SHEEPWOLF 16 minutes ago
$ILLR TRILLER GROUP CEO WING FAI NG and Mario Lopez at #BKFC KM5
https://investorshub.advfn.com/uimage/uploads/2025/1/26/muhlpSmartSelect_20250126_154850_X.jpg
ILLR
SHEEPWOLF SHEEPWOLF 16 minutes ago
$ILLR TRILLER GROUP CEO WING FAI NG and Mario Lopez at #BKFC KM5
https://investorshub.advfn.com/uimage/uploads/2025/1/26/muhlpSmartSelect_20250126_154850_X.jpg
ILLR

Your Recent History

TG
ESL
Essilorluxottica
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads